Teva Pharmaceutical (NYSE: TEVA) stock rose approximately 12.3% last week. The surge was primarily attributed to the company's second-quarter report, which showed sales of $4.1 billion, surpassing average analyst targets by roughly $70 million, and a softer-than-expected year-over-year revenue decline.
Additionally, Teva announced plans for a direct listing of its common stock on the New York Stock Exchange (NYSE), replacing its American Depositary Receipts (ADRs) starting September 14. This move is expected to attract institutional investors and retail traders.
Teva Pharmaceutical stock surged 12.3% last week, driven by better-than-expected Q2 sales and planned NYSE direct listing
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
CRI (Crypto International) Project Analysis and Market Status
-
2
SK hynix in talks with Intel over potential US memory production agreement
-
3
Fetch.ai (FET) Token Analysis: Project Status and Investment Considerations
-
4
Bybit to adjust risk limits and leverage for selected perpetual contracts including 1000XECUSDT and BLASTUSDT, effective Sep 18, 2026
-
5
Anthropic, after calling for an AI slowdown, has signed its first data center lease in Australia, planning a total capacity of 2.16 GW.
-
6
XLM Price Analysis: Stellar Lumens' Positioning, Progress, and Market Outlook
-
7
MCG Coin Analysis: The Current Status and Prospects of MetalCore, Microcap Gem, and MicroChains Gov Token
-
8
COB Token: The Rise, Fall, and Current Status of Cobinhood Exchange's Token
-
9
Nikkei: Japan's MUFG Bank to Introduce Guidelines for Financing Defense Industry
-
10
Zhipu AI's CoWork business in China is progressing rapidly, with industry orders exceeding 1 billion yuan within one month of GLM-5.3's release.
Markets Today
Recommended Reading







